Free account + included starter software — credential review typically takes 1–2 business days. See how it works
NDC 33342-0260-11

Entacapone 200 mg/1 TABLET

Available — 2-Day Shipping
NDC
33342-0260-11
Generic Name
Entacapone
Brand Name
Entacapone
Strength
200 mg/1
Dosage Form
TABLET
Route
ORAL
Package Size
—
Labeler
Macleods Pharmaceuticals Limited

FDA Drug Information

Indications & Usage

INDICATIONS Entacapone tablets are indicated as an adjunct to levodopa and carbidopa to treat end-of-dose “wearing-off” in patients with Parkinson’s disease (see CLINICAL PHARMACOLOGY, Clinical Studies). Entacapone tablets effectiveness has not been systematically evaluated in patients with Parkinson’s disease who do not experience end-of-dose “wearing-off”.

Important Warnings

WARNINGS Monoamine oxidase (MAO) and COMT are the two major enzyme systems involved in the metabolism of catecholamines. It is theoretically possible, therefore, that the combination of entacapone tablets and a non-selective MAO inhibitor (e.g., phenelzine and tranylcypromine) would result in inhibition of the majority of the pathways responsible for normal catecholamine metabolism. For this reaso…

Source: FDA. For professional use only. Not a substitute for prescribing information.

View Product Detail →
See full specifications, request 2-day shipping, and create account to view pricing
All Entacapone Strengths & Forms →
Compare all available NDC codes, strengths, and manufacturers

Wholesale and compliance resources

DSCSA compliance resource hubRead practical guidance for authorized partners, records, and traceability.Transaction information and statementsLearn about the records that accompany pharmaceutical transfers.ScriptTrack medication workflow softwareExplore the included starter workflow for verified businesses.

Order NDC 33342-0260-11 at Wholesale

Create a free Premier Pharma account to unlock live wholesale pricing and place orders with same-day fulfillment and full DSCSA T2 documentation (TI + TS).

Create AccountNDC Lookup